These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28882290)

  • 1. The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update.
    Sengupta PP; Kramer CM; Narula J; Dilsizian V
    JACC Cardiovasc Imaging; 2017 Sep; 10(9):1056-1071. PubMed ID: 28882290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
    Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive Cardiac Imaging and the Prediction of Heart Failure Progression in Preclinical Stage A/B Subjects.
    Gong FF; Campbell DJ; Prior DL
    JACC Cardiovasc Imaging; 2017 Dec; 10(12):1504-1519. PubMed ID: 29216977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered spatial distribution of the diastolic left ventricular pressure difference in heart failure.
    Iwano H; Kamimura D; Fox E; Hall M; Vlachos P; Little WC
    J Am Soc Echocardiogr; 2015 May; 28(5):597-605.e1. PubMed ID: 25691001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular ejection fraction as therapeutic target: is it the ideal marker?
    Katsi V; Georgiopoulos G; Laina A; Koutli E; Parissis J; Tsioufis C; Nihoyannopoulos P; Tousoulis D
    Heart Fail Rev; 2017 Nov; 22(6):641-655. PubMed ID: 28601914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes.
    O'Meara E; Rouleau JL; White M; Roy K; Blondeau L; Ducharme A; Neagoe PE; Sirois MG; Lavoie J; Racine N; Liszkowski M; Madore F; Tardif JC; de Denus S;
    Circ Heart Fail; 2014 Sep; 7(5):773-81. PubMed ID: 25027873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations among co-morbidity, cardiac geometries and mechanics in hospitalized heart failure with or without preserved ejection fraction.
    Lo CI; Lai YH; Chang SN; Kuo JY; Hsieh YC; Bulwer BE; Hung CL; Yeh HI
    Clin Exp Hypertens; 2017; 39(5):473-480. PubMed ID: 28569600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
    Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac molecular imaging to track left ventricular remodeling in heart failure.
    Shirani J; Singh A; Agrawal S; Dilsizian V
    J Nucl Cardiol; 2017 Apr; 24(2):574-590. PubMed ID: 27480973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
    Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.
    Hunter WG; Kelly JP; McGarrah RW; Khouri MG; Craig D; Haynes C; Ilkayeva O; Stevens RD; Bain JR; Muehlbauer MJ; Newgard CB; Felker GM; Hernandez AF; Velazquez EJ; Kraus WE; Shah SH
    J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.
    Melenovsky V; Hwang SJ; Redfield MM; Zakeri R; Lin G; Borlaug BA
    Circ Heart Fail; 2015 Mar; 8(2):295-303. PubMed ID: 25593126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation Between Echocardiogram-Based Cardiac Parameters and Outcome in Heart Failure With Preserved and Reduced Ejection Fraction.
    Obokata M; Takeuchi M; Negishi K; Ohte N; Izumo M; Yamashita E; Ebato M; Yuda S; Kurabayashi M; Nakatani S
    Am J Cardiol; 2016 Nov; 118(9):1356-1362. PubMed ID: 27600459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial dysfunction relates to symptom onset in patients with heart failure and preserved left ventricular ejection fraction.
    Sanchis L; Gabrielli L; Andrea R; Falces C; Duchateau N; Perez-Villa F; Bijnens B; Sitges M
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):62-7. PubMed ID: 25187609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
    Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.
    D'Elia E; Vaduganathan M; Gori M; Gavazzi A; Butler J; Senni M
    Eur J Heart Fail; 2015 Dec; 17(12):1231-9. PubMed ID: 26493383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.
    Tsuji K; Sakata Y; Nochioka K; Miura M; Yamauchi T; Onose T; Abe R; Oikawa T; Kasahara S; Sato M; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
    Eur J Heart Fail; 2017 Oct; 19(10):1258-1269. PubMed ID: 28370829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal evaluation of ventricular ejection fraction and NT-proBNP across heart failure subgroups.
    Martinsson A; Oest P; Wiborg MB; Reitan Ö; Smith JG
    Scand Cardiovasc J; 2018 Aug; 52(4):205-210. PubMed ID: 29656687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.